ADORA2B and neoplasm: CD73 is an independent prognostic factor in prostate cancer, as the expression of CD73 in the prostate epithelium suppresses immunosurveillance by CD8+ T cells, while the expression of CD73 in the tumor stroma reduces NF-kB signaling in tumor cells via adenosine A2B receptor.